Abstract
The incidence of gastric cancer in Israel is 28 cases per 100,000 inhabitants per year. Thirteen percent of those dying from cancer die from stomach cancer [16]. Surgical resection is the principal modality, offering the only hope for long-term disease-free survival. However, of the 20–50% of patients who can undergo “curative” resection, four out of five die from recurrent cancer within 5 years [2]. Chemotherapy has been primarily confined to palliative treatment [2, 3]. Since 1969 we have been treating radically operated patients with gastric cancer by adjuvant radio-chemotherapy and inoperable patients by radio- and chemotherapy or chemotherapy alone.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Brookes, V. S., Waterhouse, J. A. H., Powell, D. J.: Carcinoma of the stomach: a 10 year survey of results and of factors affecting prognosis. Brit. Med. J. 1, 1577 (1965).
Comis, R. L., Carter, S. K.: A review of chemotherapy in gastric cancer. Cancer 34, 1576 (1974).
Cutler, S. J.: Trends in cancers of the digestive tract. Surgery 65, 740 (1969).
Falkson, G.: Fluorinated pyrimidines as potentiators of ionizing radiations in the treatment of stomach cancer in man. M.D. Thesis, University of Pretoria, 1964.
Falkson, G., Sandison, A. G., Jacobs, E. L., Fichardt, T.: Combined telecobalt and 5-fluorouracil therapy in cancer of the stomach. S. African Med. J. 36, 712–717 (1963).
Falkson, G., Van Eden, E. B., Falkson, H. C.: Fluorouracil, imidazole carboxamide dimethyl triazeno, vincristine and bischloroethyl nitrosourea in colon cancer. Cancer 33, 1207–1209 (1974).
Kennedy, B. J.: TNM classification for stomach cancer. Cancer 26, 971 (1970).
Mc Meer, G. T., Lawrence, W., Ashley, M. P., Pack, G. T.: End results in the treatment of gastric cancer. Surgery 43, 879 (1958).
Modan, B., Kallner, H.: Gastrointestinal cancer in Israel. Isr. J. Med. 7, 1475–1478 (1971).
Moertel, C. G., Childs, D. S., Reitemeier, R. J., Colby, M. Y., Holbrok, M. A.: Combined 5FU and supervoltage radiation therapy of locally unresected gastrointestinal carcinoma. Lancet (1969) II, 865.
Moertel, C. G., Mittelman, J. H. et al: Sequential and combination chemotherapy of advanced gastric cancer. Cancer 38, 678–682 (1976).
Moertel, C. G., Ritts, R. E., Schutt, A. J., Jr., Hahn, R. G.: Clinical studies of methanol extraction residue fraction of bacillus calmette-guerin as an immunostimulant in patients with advanced cancer. Cancer Research 35, 3075–3083 (1975).
Moertel, C. G., Schutt, A. J., Reitemeier, R. J., Hahn, R. G.: Therapy for gastrointestinal cancer with nitrosoureas alone and in drug combination. Cancer treatment reports 60, 729 (1976).
Rachmani, J. et al: Cancer of the stomach. Harefuah 86, 445–450 (1974).
Robinson, E., Bartal, A., Cohen, Y., Haasz, R.: A preliminary report on the effect of MER on cancer patients. Brit. J. Cancer 32, 1–4 (1975).
Steinitz, R., Costin, C.: Cancer in Israel. Facts and figures 1960–1966. Ministry of Health (1970).
U.S.A. Department of Health, Education and Welfare: End results in cancer. NIH, Report No. 4, 47 (1972).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1977 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Robinson, E., Cohen, Y. (1977). The Combination of Surgery, Radiotherapy, and Chemotherapy in the Treatment of Gastric Cancer. In: Mathé, G. (eds) Tactics and Strategy in Cancer Treatment. Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, vol 62. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81174-6_26
Download citation
DOI: https://doi.org/10.1007/978-3-642-81174-6_26
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-81176-0
Online ISBN: 978-3-642-81174-6
eBook Packages: Springer Book Archive